Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch & Lomb CorpBLCO · Entity 3756 | EVP and CFO | August 05, 2026 | August 07, 2026 |
| Bausch Health Companies Inc.BHC · Entity 4363 | EVP & Chief Financial Officer | March 03, 2022 | March 07, 2022 |
| TE Connectivity plcTEL · Entity 3004 | Director | November 13, 2025 | November 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch & Lomb Corp
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 393,527 |
Reported balance
After 2026-08-05 transaction · row 1
1 source rowRow 1 · 2026-08-05 · Grant · Acquired 50,335 · Balance 393,527 F1: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on February 28, 2024 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2026. The earned PSUs will vest on February 28, 2027, subject generally to the reporting person's continued employment through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on February 28, 2024 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2026. The earned PSUs will vest on February 28, 2027, subject generally to the reporting person's continued employment through such date.
Bausch Health Companies Inc.
Report date March 03, 2022 · Filed March 07, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 119,455 |
Reported balance
After 2022-03-03 transaction · row 1
1 source rowRow 1 · 2022-03-03 · Tax withholding · Disposed 1,242 · Balance 119,455 F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. |
Filing footnotes · ownership attribution and instrument terms
F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
TE Connectivity plc
Report date November 13, 2025 · Filed November 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 1,206 |
Ending reported balance
After 2025-11-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-11-13 · Grant · Acquired 838 · Balance 1,609 F1: Grant of shares by the Issuer under directors' compensation program and Issuer's stock and incentive plan. Row 2 · 2025-11-13 · Tax withholding · Disposed 403 · Balance 1,206 |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of shares by the Issuer under directors' compensation program and Issuer's stock and incentive plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2026 Filed Aug 7, 2026 20:42 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 50,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000092 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 393,527 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on February 28, 2024 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2026. The earned PSUs will vest on February 28, 2027, subject generally to the reporting person's continued employment through such date. Read SEC document |
| May 05, 2026 Filed May 7, 2026 20:44 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 63,938 | $16.00 | $1,023,008.00 |
DisclosureSEC source: 0001860742-26-000070 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,192 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:34 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000055 · form4.xml · nonDerivative · entry 2 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 407,130 F1 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:34 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | PurchaseCommon Shares, No Par Value | 4,000 | $17.13 | $68,520.00 |
DisclosureSEC source: 0001860742-26-000055 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,130 Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 22:45 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 51,470 | $18.30 | $941,901.00 |
DisclosureSEC source: 0001860742-26-000042 · form4.xml · nonDerivative · entry 3 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,130 F2 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of performance-based restricted share units. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 22:45 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 15,507 | $18.30 | $283,778.10 |
DisclosureSEC source: 0001860742-26-000042 · form4.xml · nonDerivative · entry 2 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,600 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:45 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 7,062 | $18.49 | $130,576.38 |
DisclosureSEC source: 0001860742-26-000042 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 466,107 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:04 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 81,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000029 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 473,169 F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:34 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 70,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000009 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,394 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 18:40 UTC | TE Connectivity plc TEL · Entity 3004 | Tax withholdingCommon Shares | 403 | $236.28 | $95,220.84 |
DisclosureSEC source: 0001225208-25-009156 · doc4.xml · nonDerivative · entry 2 Eldessouky Sam · CIK 0001558676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,206 Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 18:40 UTC | TE Connectivity plc TEL · Entity 3004 | GrantCommon Shares | 838 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009156 · doc4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,609 F1 · shares: Grant of shares by the Issuer under directors' compensation program and Issuer's stock and incentive plan. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 20:46 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 42,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020242 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,816 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2025. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 21:53 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 3,996 | $14.32 | $57,222.72 |
DisclosureSEC source: 0001127602-25-019662 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,299 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:25 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 141,630 | $0.00 Strike: $15.86 | $0.00 |
DisclosureSEC source: 0001127602-25-007267 · form4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,630 Underlying: Common Shares, No Par Value · 141,630 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:25 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 59,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007267 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,295 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:13 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 8,582 | $17.83 | $153,017.06 |
DisclosureSEC source: 0001127602-24-030052 · form4.xml · nonDerivative · entry 2 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,836 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:13 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 7,249 | $17.83 | $129,249.67 |
DisclosureSEC source: 0001127602-24-030052 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,418 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 21:16 UTC | TE Connectivity plc TEL · Entity 3004 | Tax withholdingCommon Shares | 556 | $153.25 | $85,207.00 |
DisclosureSEC source: 0001225208-24-009986 · doc4.xml · nonDerivative · entry 2 Eldessouky Sam · CIK 0001558676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 771 Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 21:16 UTC | TE Connectivity plc TEL · Entity 3004 | GrantCommon Shares | 1,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009986 · doc4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,327 F1 · price: Grant of shares by the Issuer under directors' compensation program and Issuer's stock and incentive plan. Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 23:17 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 5,113 | $15.53 | $79,404.89 |
DisclosureSEC source: 0001127602-24-021128 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,667 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:32 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 4,854 | $16.47 | $79,945.38 |
DisclosureSEC source: 0001127602-24-008141 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,780 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:28 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 152,439 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001127602-24-007889 · form4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,439 Underlying: Common Shares, No Par Value · 152,439 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:28 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 50,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007889 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,634 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:03 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 4,218 | $19.82 | $83,600.76 |
DisclosureSEC source: 0001127602-23-021411 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,299 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:56 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 136,116 | $0.00 Strike: $17.96 | $0.00 |
DisclosureSEC source: 0001127602-23-008774 · form4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,116 Underlying: Common Shares, No Par Value · 136,116 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase Common Shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:56 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 42,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008774 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,517 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 23:40 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019825 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| May 05, 2022 Filed May 9, 2022 22:44 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 494,505 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017319 · doc4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,505 Underlying: Common Shares, No Par Value · 494,505 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase Common Shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| May 05, 2022 Filed May 9, 2022 22:44 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017319 · doc4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 22:41 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,242 | $23.61 | $29,323.62 |
DisclosureSEC source: 0001127602-22-008490 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,455 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:00 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionRestricted Share Units · Derivative | 8,674 | $24.35 Strike: $24.35 | $211,211.90 |
DisclosureSEC source: 0000899243-22-008806 · doc4.xml · derivative · entry 6 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 0 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:00 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantRestricted Share Units · Derivative | 8,674 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-008806 · doc4.xml · derivative · entry 5 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 8,674 shares Expires 2022-02-27 F2 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis F2 · price: Each PSU converts into Common Shares on a one-for-one basis F1 · derivative.exercise_date: Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:00 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 918 | $24.35 | $22,353.30 |
DisclosureSEC source: 0000899243-22-008806 · doc4.xml · nonDerivative · entry 4 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,697 F5 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:00 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 3,102 | $24.35 | $75,533.70 |
DisclosureSEC source: 0000899243-22-008806 · doc4.xml · nonDerivative · entry 2 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,429 F3 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:00 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionCommon Shares, No Par Value | 8,674 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-008806 · doc4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer. F2 · price: Each PSU converts into Common Shares on a one-for-one basis Read SEC document |
| February 26, 2022 Filed Mar 3, 2022 02:00 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 814 | $24.35 | $19,820.90 |
DisclosureSEC source: 0000899243-22-008806 · doc4.xml · nonDerivative · entry 3 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,615 F4 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs"). Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 20:11 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 17,000 | $31.68 | $538,585.50 |
DisclosureSEC source: 0001127602-21-019904 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,857 F1 · price: The price in Column 4 reflects the average weighted sale price for the transactions aggregated on this Form 4. The sales price per share reported on this Form 4 range from $31.67 to $31.711. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:26 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 122,427 | $32.03 Strike: $32.03 | $3,921,336.81 |
DisclosureSEC source: 0001127602-21-019037 · form4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,427 Underlying: Common Shares, No Par Value · 122,427 shares Expires 2031-06-01 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:26 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 33,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-019037 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,857 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 01:51 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 7,361 | $32.97 | $242,692.17 |
DisclosureSEC source: 0001127602-21-010162 · form4.xml · nonDerivative · entry 3 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,184 F3 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:51 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionRestricted Share Units · Derivative | 4,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010162 · form4.xml · derivative · entry 4 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,404 shares Expires 2021-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. F4 · derivative.exercise_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F4 · derivative.expiration_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F5 · balance_after: This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 7,104 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:51 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 13,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010162 · form4.xml · nonDerivative · entry 2 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,545 F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:51 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionCommon Shares, No Par Value | 4,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010162 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:55 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantNon-qualified Stock Options (right To Purchase) · Derivative | 16,374 | $0.00 Strike: $32.56 | $0.00 |
DisclosureSEC source: 0001127602-21-009562 · form4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,374 Underlying: Common Shares, No Par Value · 16,374 shares Expires 2031-03-03 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:55 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 10,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009562 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,611 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:33 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,739 | $31.42 | $54,639.38 |
DisclosureSEC source: 0001127602-21-009157 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,313 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 09, 2020 Filed Mar 12, 2020 00:55 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,749 | $20.96 | $36,659.04 |
DisclosureSEC source: 0001127602-20-010323 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,052 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:20 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 869 | $24.44 | $21,238.36 |
DisclosureSEC source: 0001127602-20-009128 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,801 F1 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:24 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantNon-qualified Stock Options (right To Purchase) · Derivative | 28,429 | $0.00 Strike: $24.77 | $0.00 |
DisclosureSEC source: 0001127602-20-008437 · form4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,429 Underlying: Common Shares, No Par Value · 28,429 shares Expires 2030-02-26 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:24 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 6,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008437 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,670 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.